Cherries may help reduce metabolic syndrome and heart disease risk factorsApril 30, 2007New study finds cherry-enriched diets lowered blood cholesterol, insulin levels and other factors linked to this 'silent epidemic' WASHINGTON, DC, April 30 - Increasing intake of antioxidant-rich cherries may help lower the risk of metabolic syndrome and cardiovascular disease, suggests a new study(1) presented today at the Experimental Biology annual meeting. Researchers say the animal study is encouraging and will lead to further clinical studies in humans. "Metabolic syndrome is a cluster of traits that can greatly increase your risk of heart disease, stroke and Type 2 diabetes, so it's a serious condition that significantly affects public health," said study co-author Dr. Steven F. Bolling, a cardiac surgeon at the University of Michigan Cardiovascular Center who also heads the U-M Cardioprotection Research Laboratory, where the study was performed. "Lifestyle changes have been shown to lower the odds of developing metabolic syndrome, and there is tremendous interest in studying the impact of particular foods that are rich in antioxidants, such as cherries." Metabolic syndrome (also called insulin resistance syndrome) has become increasingly common in the United States, especially among adults in their mid-30s. The American Heart Association estimates that 50 million American adults have it, and many of them don't even know it. That's why metabolic syndrome is frequently called a "silent epidemic." The study, presented by University of Michigan researchers, used cherry powder derived from tart cherries - the variety frequently sold as dried, frozen or juice. These cherries contain a compound known as anthocyanins, which provide the deep rich red color and have been shown to have anti-inflammatory properties and other health benefits. In the new study, whole tart cherry powder was fed to two groups of rats as either 1 percent or 10 percent of their diet for 90 days. Other rats received diets with no cherry powder, but with an equal amount of carbohydrates and calories to those that received cherry powder. Results showed that the cherry-enriched diets significantly lowered total cholesterol levels, triglycerides, insulin and fasting glucose levels after 90 days. All of these measures are factors that are linked to metabolic syndrome. The study also showed the cherry-fed groups had lower levels of a plasma marker of oxidative damage and increased blood antioxidant capacity - not surprising since cherries are one of the richest sources of antioxidants. Additionally, the cherry-enriched diets reduced "fatty liver" or the accumulation of triglycerides and cholesterol in the liver. The amount of cherries used in the study is estimated to be about 1 ¼ to 1 ½ cups of whole frozen cherries or a little more than ½ cup of dried cherries. People with metabolic syndrome - characterized by abdominal obesity (or belly fat), high triglycerides, low HDL cholesterol levels, high blood pressure and high blood sugar levels - are at greater risk for cardiovascular disease, which remains the nation's top killer. Previous studies have shown that the compounds in cherries may offer protection against heart disease due to enhancements in blood vessel health. Other studies suggest that cherries have anti-inflammatory benefits that may help ease the pain of arthritis and gout. ### The new study on cherries and metabolic syndrome has been submitted for publication. The study was funded by the Cherry Marketing Institute, which provided an unrestricted grant to the University of Michigan to conduct the research and was not directly involved in the design, conduct or analysis of the project. (1) Cherry-enriched diets reduce metabolic syndrome and oxidative stress in lean Dahl-SS rats. Experimental Biology 2007 225.8, Seymour EM, Singer AAM, Bennink MR, Bolling SF. Presented in minisymposium 225, Dietary Bioactive Compounds: Chronic Disease Risk Reduction. Weber Shandwick Worldwide |
|||||||||||||||||||||
| Related Metabolic Syndrome Current Events and Metabolic Syndrome News Articles Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Night Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep. Postmenopausal women with higher testosterone levels Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels. Researchers identify the three killer indicators that are even worse than high cholesterol Researchers at the University of Warwick have identified a particular combination of health problems that can double the risk of heart attack and cause a three-fold increase in the risk of mortality. Canadian scientists link fat hormone to death from potentially deadly blood infection A new Canadian study has found that lower-than-normal levels of a naturally-occurring fat hormone may increase the risk of death from sepsis-an overwhelming infection of the blood which claims thousands of lives each year. Extra care for outwardly healthy workers costs companies millions annually Someone healthy enough to work could still cost an employer more than $4,000 annually in unnecessary health care costs. Research indicates vegetable juice can be an easy, enjoyable way to increase daily intake Decades of studies have documented the link between eating a diet rich in vegetables and multiple health benefits, yet nearly eight out of 10 people worldwide fall short of the daily recommendation. Common herbicides and fibrates block nutrient-sensing receptor found in gut and pancreas According to new research from the Monell Center and the Mount Sinai School of Medicine, certain common herbicides and lipid-lowering fibrate drugs act in humans to block T1R3, a nutrient-sensing taste receptor also present in intestine and pancreas. CHEO RI study uses sophisticated genetic engineering to improve insulin-producing beta cells One of the biggest mysteries about diabetes is why specialized cells in the pancreas stop secreting insulin, which the body needs in order to store glucose from food. Metabolic syndrome linked to liver disease in obese teenaged boys Researchers studying a large sample of adolescent American boys have found an association between metabolic syndrome, which is a complication of obesity, and elevated liver enzymes that mark potentially serious liver disease. More Metabolic Syndrome Current Events and Metabolic Syndrome News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||